Butterfly Network (BFLY) Cash from Operations Growth (1y) (2021 - 2026)
Butterfly Network (BFLY) Cash from Operations Growth (1y) (2021 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Ops. Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.44 Bn | 193.84 Bn | 7.27 Bn | 21.54% |
| 2 | Stryker | 127.32 Bn | 123.85 Bn | 4.50 Bn | 13.50% |
| 3 | Medtronic | 118.87 Bn | 109.65 Bn | 6.41 Bn | 1.78% |
| 4 | Boston Scientific | 73.47 Bn | 72.93 Bn | 3.85 Bn | 14.62% |
| 5 | Edwards Lifesciences | 51.90 Bn | 47.65 Bn | 1.35 Bn | 124.64% |
| 6 | Dexcom | 34.30 Bn | 32.36 Bn | 830.00 Mn | -11.16% |
| 7 | GE HealthCare Technologies | 33.74 Bn | 31.63 Bn | 2.18 Bn | 78.72% |
| 8 | Koninklijke Philips | 26.35 Bn | 23.03 Bn | 4.55 Bn | -0.23% |
| 9 | Steris | 23.05 Bn | 22.56 Bn | 684.20 Mn | -12.60% |
| 10 | Butterfly Network | 2.41 Bn | 2.29 Bn | 23.29 Mn | -127.00% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -127.00% |
| Mar 31, 2026 | -18.99% |
| Dec 31, 2025 | 389.46% |
| Sep 30, 2025 | 63.55% |
| Jun 30, 2025 | 28.33% |
| Mar 31, 2025 | 43.50% |
| Dec 31, 2024 | 76.19% |
| Sep 30, 2024 | 50.44% |
| Jun 30, 2024 | 62.24% |
| Mar 31, 2024 | 52.22% |
| Dec 31, 2023 | 54.60% |
| Sep 30, 2023 | 61.97% |
| Jun 30, 2023 | 39.80% |
| Mar 31, 2023 | 20.25% |
| Dec 31, 2022 | 32.54% |
| Sep 30, 2022 | 9.58% |
| Jun 30, 2022 | -20.53% |
| Mar 31, 2022 | 14.49% |
| Dec 31, 2021 | -107.42% |
| Sep 30, 2021 | -114.48% |